News & Events

News

Bioquell Launches High Performance Mobile Room Bio-Decontamination System

June 2019

Bioquell ProteQ offers major cost benefits, a modular, upgradeable design and new features including wireless connectivity, built-in aeration & graphical user interface Bioquell (www.bioquell.com) – a leading global expert in reducing the risk of bio-contamination in the pharmaceutical, life science and healthcare markets – has launched the cost effective and high performance Bioquell ProteQ mobile […]

Formaldehyde – what does the future hold?

January 2019

John Chewins, Director, Scientific & Regulatory Affairs – Bioquell As most laboratory professionals will be aware, on the 1st January 2016, the EU officially adopted the reclassification of Formaldehyde, under the CLP (Classification, Labelling and Packaging) Regulations EC 1272/2008, as a Class 1B Carcinogen and Class 2 Mutagen. In simple terms, a Class 1B identification […]

Bioquell Highlights Advanced Bio-decontamination Solutions for the Pharmaceutical Industry

November 2018

BIOQUELL HIGHLIGHTS ADVANCED BIO-DECONTAMINATION SOLUTIONS FOR THE PHARMACEUTICAL INDUSTRY Bioquell (www.bioquell.com) is highlighting its wide range of advanced bio-decontamination solutions for the pharmaceutical industry. Bioquell’s Rapid Bio-decontamination Service (RBDS) is available on a 24/7 basis and reacts quickly to eliminate pathogens, stop escalated incidents and handle emergency response situations. The Bioquell Z-2 incorporates a Hydrogen […]

Bioquell to Highlight Bio-Decontamination Solutions for Reduced Risk of Healthcare-Associated Infections

August 2018

Latest developments utilizing Bioquell Hydrogen Peroxide Vapour help avoid unexpected, costly incidents, limit the impact of an outbreak & ensure patient safety Bioquell – one of the leading global experts in reducing the risk of bio-contamination in the healthcare industry – will be highlighting its range of bespoke solutions for eliminating healthcare-associated infections (HAIs). The Bioquell […]

Reducing the Risk of Bio-contamination in Gene, Cell and CAR-T Therapy

August 2018

Bioquell’s Dr Rolf Hansen examines how the latest isolator systems create aseptic working conditions for reducing risk and keeping gene, cell and CAR-T therapies efficient, compliant and accurate, whilst also supporting biologics manufacturing expansion and enabling more patients to be treated at the same time. Gene, cell and CAR-T therapies are the latest techniques that […]

More News